Longhorn Vaccines and Diagnostics to Showcase PrimeStore® Molecular Transport Medium at Two European Veterinary Health Conferences
Bethesda, MD and Gaithersburg, MD, June 4, 2024 – Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, will showcase the company’s core diagnostic product, PrimeStore® Molecular Transport Medium (MTM), at two European veterinary conferences in June. Longhorn will participate in the 27th International Pig Veterinary Society Congress (IPVS) & 15th European Symposium of Porcine Health Management (ESPHM), taking place in Leipzig, Germany, from June 4-7, 2024 and the 9th International Conference on Emerging Zoonoses (ZOO), taking place in Palermo, Italy, from June 9-12, 2024.
Highly infectious diseases pose major global public health issues for governments and animal organizations, and can have repercussions such as decreased food supply, increased costs of food and even the potential for viruses to jump to humans. A key factor in preventing and tracking the spread of viral diseases such as influenza, African swine fever, and Covid-19 is having testing tools that are safe, fast and cost-effective. PrimeStore MTM works by completely and effectively inactivating viruses and preserves both RNA and DNA nucleic acids at ambient temperatures for molecular diagnostics.
“Attending these highly regarded animal health conferences provide us the opportunity to collaborate with peers on the best solutions for combating highly infectious diseases, a global effort that requires the right technology to test and track viruses that can spread quickly,” said Jerry Torrison, DVM, PhD, Senior Vice President of Animal Health of Longhorn Vaccines and Diagnostics. “PrimeStore MTM is a unique diagnostic solution that has applications across a number of high impact zoonotic diseases. At both IPVS-ESPHM and ZOO we plan to demonstrate how the reliability, efficiency and scalability of PrimeStoreMTM helps governments and health organizations around the world.”
For more information about Longhorn, visit www.LHNVD.com.
About Longhorn Vaccines and Diagnostics
Longhorn Vaccines and Diagnostics is a closely held One Health company based in Maryland that is developing broad coverage vaccines and diagnostic tools for worldwide public health concerns and to prevent future pandemics. Since its inception in 2006, Longhorn has focused on developing broad coverage vaccines and diagnostic tools that can impact a pandemic on a global scale and at all socio-economic levels. Since pandemics flow between humans and animals, Longhorn products play a significant role to surveil, diagnose, prevent and treat the next infectious disease.
Longhorn’s core product, PrimeStore® Molecular Transport Medium (MTM), is a patented, FDA cleared, state-of-the-art ambient temperature molecular diagnostic collection and transport device that can help governments, global health organizations, and drug manufacturers improve the diagnosis and treatment of highly infectious diseases such as Influenza, SARS-CoV-2, and Mycobacterium tuberculosis (TB). Unlike standard devices for collecting and transporting virus samples, PrimeStore® MTM is the first molecular transport device that can safely deactivate pathogens and stabilize RNA and DNA, allowing enhanced point of care and ambient temperature transport for laboratory based molecular testing and characterization.
Contacts:
Longhorn Vaccines and Diagnostics LLC
Jeffrey Fischer
Email: jeff@lhnvd.com
Media
Alexis Feinberg – ICR Westwicke PR
Email: alexis.feinberg@westwicke.com
Investor Relations
Stephanie Carrington – ICR Westwicke IR
Email: stephanie.carrington@westwicke.com
###
